These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 22428298)

  • 1. [Ocular surface in glaucoma patients with topical treatment].
    Zemba M; Papadatu CA; Enache VE; Sârbu LN
    Oftalmologia; 2011; 55(3):94-8. PubMed ID: 22428298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana.
    Kobia-Acquah E; Gyekye GA; Antwi-Adjei EK; Koomson NY; Cobbina F; Donkor R; Akowuah PK
    J Glaucoma; 2021 Feb; 30(2):180-186. PubMed ID: 33074962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.
    Saade CE; Lari HB; Berezina TL; Fechtner RD; Khouri AS
    Can J Ophthalmol; 2015 Apr; 50(2):132-6. PubMed ID: 25863853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye.
    Wong ABC; Wang MTM; Liu K; Prime ZJ; Danesh-Meyer HV; Craig JP
    Ocul Surf; 2018 Jul; 16(3):289-293. PubMed ID: 29510226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of ocular surface disease in glaucoma patients.
    Leung EW; Medeiros FA; Weinreb RN
    J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tear film status in glaucoma patients.
    Jandroković S; Suić SP; Kordić R; Kuzman T; Petricek I
    Coll Antropol; 2013 Apr; 37 Suppl 1():137-40. PubMed ID: 23837233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tear film osmolarity in patients treated for glaucoma or ocular hypertension.
    Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
    Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.
    Guarnieri A; Carnero E; Bleau AM; Alfonso-Bartolozzi B; Moreno-Montañés J
    Int Ophthalmol; 2020 Mar; 40(3):741-751. PubMed ID: 31813109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lack of concordance between dry eye syndrome questionnaires and diagnostic tests].
    Fuentes-Páez G; Herreras JM; Cordero Y; Almaraz A; González MJ; Calonge M
    Arch Soc Esp Oftalmol; 2011 Jan; 86(1):3-7. PubMed ID: 21414523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy.
    Roberti G; Agnifili L; Berardo F; Riva I; Figus M; Manni G; Quaranta L; Oddone F
    Adv Ther; 2018 May; 35(5):686-696. PubMed ID: 29687335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Dry Eye Syndrome Using Ocular Surface Disease Index, Tear Film Break-up Time, and Schirmer Test.
    Humayun S; Noor M; Shahid M; Naqvi SAH; Ishaq M; Humayun Q
    J Coll Physicians Surg Pak; 2024 Mar; 34(3):308-312. PubMed ID: 38462866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry eye symptom questionnaires show adequate measurement precision and psychometric validity for clinical assessment of vision-related quality of life in glaucoma patients.
    Ocansey S; Antiri EO; Abraham CH; Abu EK
    PLoS One; 2023; 18(3):e0283597. PubMed ID: 36961801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms and signs of tear film dysfunction in glaucomatous patients.
    Valente C; Iester M; Corsi E; Rolando M
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):281-5. PubMed ID: 21557633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.
    Garcia DM; Reis de Oliveira F; Módulo CM; Faustino J; Barbosa AP; Alves M; Rocha EM
    PLoS One; 2018; 13(12):e0208420. PubMed ID: 30507949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia.
    Sahlu M; Giorgis AT
    BMC Ophthalmol; 2021 Mar; 21(1):155. PubMed ID: 33785013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes.
    Kallarackal GU; Ansari EA; Amos N; Martin JC; Lane C; Camilleri JP
    Eye (Lond); 2002 Sep; 16(5):594-600. PubMed ID: 12194075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of artificial tears on automated visual field testing in patients with glaucoma and dry eye.
    Kocabeyoglu S; Mocan MC; Bozkurt B; Irkec M
    Can J Ophthalmol; 2013 Apr; 48(2):110-4. PubMed ID: 23561604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops.
    Pérez Bartolomé F; Martínez de la Casa JM; Arriola Villalobos P; Fernández Pérez C; Polo V; Sánchez Jean R; García Feijoó J
    Semin Ophthalmol; 2018; 33(5):643-650. PubMed ID: 29144869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.